Regulatory role of nitric oxide in the reduced survival of erythrocytes in visceral leishmaniasis

Biochimica et Biophysica Acta - General Subjects

Volumn 1800, Issue 9, 2010, Pages 964-976

  Chowdhury, Kaustav Dutta ^a   Sen, Gargi ^a   Biswas, Tuli ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Calcium homeostasis; Caspase 3; Erythrophagocytosis; Nitric oxide (NO); Transbilayer lipid asymmetry; Visceral leishmaniasis (VL)

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CARRIER PROTEIN; CASPASE 3; ERYTHROCYTE BAND 3 PROTEIN; ISOSORBIDE DINITRATE; LIPOCORTIN 5; NITRIC OXIDE; SCRAMBLASE; STIBOGLUCONATE SODIUM; ADENOSINE TRIPHOSPHATE; ANTIMONY GLUCONATE; ANTIPROTOZOAL AGENT; CALCIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROPHAGOCYTOSIS; FLOW CYTOMETRY; HEMOLYSIS; MACROPHAGE; MALE; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEPLETION; PROTEIN SYNTHESIS; VISCERAL LEISHMANIASIS; ANIMAL; DRUG EFFECTS; HAMSTER; HUMAN; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MESOCRICETUS; METABOLISM; PARASITOLOGY; PHAGOCYTOSIS; SIGNAL TRANSDUCTION;

ANIMALIA; CRICETINAE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANION EXCHANGE PROTEIN 1, ERYTHROCYTE; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CALCIUM; CASPASE 3; CELL SURVIVAL; CRICETINAE; ERYTHROCYTES; HEMOLYSIS; HUMANS; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MACROPHAGES; MALE; MESOCRICETUS; NITRIC OXIDE; PHAGOCYTOSIS; SIGNAL TRANSDUCTION;

EID: 77955273873     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2010.05.008     Document Type: Article

References (61)

1. Woodruff A.W., Topley E., Knight R., Downie C.G.B. The anaemia of Kala Azar. Br. J. Haematol. 1972, 22:319-329.
2. Miescher P.A., Belehu A. Leishmaniasis: hematologic aspects. Semin. Hematol. 1982, 19:93-99.
3. Sen G., Mukhopadhaya R., Ghosal J., Biswas T. Combination of ascorbate and α-tocopherol as a preventive therapy against structural and functional defects of erythrocytes in visceral leishmaniasis. Free Radic. Res. 2004, 38:527-534.
4. Sen G., Biswas D., Ray M., Biswas T. Albumin-quercetin combination offers a therapeutic advantage in the prevention of reduced survival of erythrocytes in visceral leishmaniasis. Blood Cells Mol. Dis. 2007, 39:245-254.
5. Forget G., Gregory D.J., Whitcombe L.A., Olivier M. Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production. Infect. Immun. 2006, 74:6272-6279.
6. Fischer U.M., Schindler R., Brixius K., Mehlhorn U., Bloch W. Extracorporeal circulation activates endothelial nitric oxide synthase in erythrocytes. Ann. Thorac. Surg. 2007, 84:2000-2003.
7. Nicolay J.P., Liebig G., Niemoeller O.M., Koka S., Ghashghaeinia M., Wieder T., Haendeler J., Busse R., Lang F. Inhibition of suicidal erythrocyte death by nitric oxide. Eur. J. Physiol. 2008, 456:293-305.
8. Rees D.D., Palmer R.M.J., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. U.S.A. 1989, 86:3375-3378.
9. Stauber L.A., Franchino E.M., Green J. A eight day method for screening compounds against Leishmania donovani in the golden hamsters. J. Protozool. 1958, 5:269-273.
10. Kelly J.W., Scott J., Sandland M., Van der Weyden M.B., Marks R. Vitamin E and dapsone-induced hemolysis. Arch. Dermatol. 1984, 120:1582-1584.
11. McElhinney B., Poynter M.E., Shrivastava P., Hazen S.L., Janssen-Heininger Y.M.W. Eosinophil peroxidase catalyzes JNK-mediated membrane blebbing in a Rho kinase-dependent manner. J. Leukoc. Biol. 2003, 74:897-907.
12. 51. Blood 1955, 10:646-649.
13. Lutz H.U., Bussolino F., Flepp R., Fasler S., Stammler P., Kazatchkine M.D., Arese P. Naturally occurring anti-band-3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocytes. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:7368-7372.
14. Mithofer K., Schmidt J., Gebhard M.M., Buhr H.J., Herfarth C., Klar E. Measurement of blood flow in pancreatic exchange capillaries with FITC-labeled erythrocytes. Microvasc. Res. 1995, 49:33-48.
15. McEvoy L., Williamson P., Schlegel R.A. Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages. Proc. Natl Acad. Sci. USA 1986, 83:3311-3315.
16. Callahan M.K., Williamson P., Schlegel R.A. Surface expression of phosphatidylserine on macrophages is required for phagocytosis of apoptotic thymocytes. Cell Death Differ. 2000, 7:645-653.
17. Schmidt H.H.H.W., Kelm M. Determination of nitrite and nitrate by the Griess reaction. Methods in nitric oxide research 1996, 491-497. John Wiley and Sons, Chichester, UK. M. Feelisch, J.S. Stamler (Eds.).
18. Planchet E., Kaiser W.M. Nitric oxide (NO) detection by DAF fluorescence and chemiluminescence: a comparison using abiotic and biotic NO sources. J. Exp. Bot. 2006, 57:3043-3055.
19. Francis P.S. The determination of urea in wine-a review. Aust. J. Grape Wine Res. 2006, 12:97-106.
20. Moss M.B., Brunini T.M.C., Soares de Moura R., Novaes Malagris L.E., Roberts N.B., Ellory J.C., Mann G.E., Mendes Ribeiro A.C. Diminished l-arginine bioavailability in hypertension. Clin. Sci. 2004, 107:391-397.
21. Wang C., Nguyen H.N., Maguire J.L., Perry D.C. Role of intracellular calcium stores in cell death from oxygen-glucose deprivation in a neuronal cell line. J. Cereb. Blood Flow Metab. 2002, 22:206-214.
22. Leach F.R. ATP determination with firefly luciferase. J. Appl. Biochem. 1981, 3:473-517.
23. 2+) activated ATPase of erythrocyte membranes. Arch. Biochem. Biophys. 1977, 179:578-583.
24. 2+)-activated membrane ATPases in human red cells and their possible relations to cation transport. Biochem. Biophys. Acta 1971, 241:379-392.
25. Ames B.N., Dubin D.T. The role of polyamines in the neutralization of bacteriophage deoxyribonucleic acid. J. Biol. Chem. 1960, 235:769-775.
26. Kannan R., Labotka R., Low P.S. Isolation and characterization of the hemichrome-stabilized membrane protein aggregates from sickle erythrocytes. J. Biol. Chem. 1988, 263:13766-13773.
27. Waugh S.M., Low P.S. Hemichrome binding to band3 nucleation of heinz bodies on the erythrocyte membrane. Biochemistry 1985, 24:34-39.
28. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 1979, 76:4350-4354.
29. Cobb C.E., Beth A.H. Identification of the eosinyl-5-maleimide reaction site on the human erythrocyte anion-exchange protein: overlap with the reaction sites of other chemical probes. Biochemistry 1990, 29:8283-8290.
30. Tokumasu F., Fairhurst R.M., Ostera G.R., Brittain N.J., Hwang J., Wellems T.E., Dvorak J.A. Band3 modifications in Plasmodium falciparum-infected AA and CC erythrocytes assayed by autocorrelation analysis using quantum dots. J. Cell Sci. 2005, 118:1091-1098.
31. Mannu F., Arese P., Cappellini M.D., Fiorelli G., Cappadoro M., Giribaldi G., Turrini F. Role of hemichrome binding to erythrocyte membrane in the generation of band-3 alterations in β-thalassemia intermedia erythrocytes. Blood 1995, 86:2014-2020.
32. Franco R., Panayiotidis M.I., Cidlowski J.A. Glutathione depletion is necessary for apoptosis in lymphoid cells independent of reactive species formation. J. Biol. Chem. 2007, 282:30452-30465.
33. Haendeler J., Hoffmann J., Tischler V., Berk B.C., Zeiher A.M., Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on s-nitrosylation at cysteine 69. Nature Cell Biol. 2002, 4:743-749.
34. Tanaka T., Hosoi F., Iwai Y.Y., Nakamura H., Masutani H., Ueda S., Nishiyama A., Takeda S., Wada H., Spyrou G., Yodoi J. Thioredoxin-2 (Trx-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO J. 2002, 21:1695-1703.
35. Mannick J.B., Schonhoff C., Papeta N., Ghafourifar P., Szibor M., Kezhong F., Gaston B. S-nitrosylation of mitochondrial caspases. J. Cell Biol. 2001, 154:1111-1116.
36. Mandal D., Mazumder A., Das P., Kundu M., Basu J. Fas-, caspase 8-, and caspase3 dependent signaling regulates the activity of the aminophospholipid translocase and phosphatidylserine externalization in human erythrocytes. J. Biol. Chem. 2003, 280:39460-39467.
37. Jenkins C.E., Swiatoniowski A., Issekutz A.C., Lin T.J. Pseudomonas aeruginosa exotoxin A induces human mast cell apoptosis by a caspase-8 and - 3 dependent mechanism. J. Biol. Chem. 2004, 279:37201-37207.
38. Tyurina Y.Y., Serinkan B., Tyurin V.A., Kini V., Yalowich J.C., Schroit A.J., Fadeel B., Kagan V.E. Lipid antioxidant, etoposide, inhibits phosphatidylserine externalization and macrophage clearance of apoptotic cells by preventing phosphatidylserine oxidation. J. Biol. Chem. 2004, 279:6056-6064.
39. Frasch S.C., Henson P.M., Kailey J.M., Richter D.A., Janes M.S., Fadok V.A., Bratton D.L. Regulation of phospholipid scramblase activity during apoptosis and cell activation by protein kinase Cδ. J. Biol. Chem. 2000, 275:23065-23073.
40. Sahu S.K., Gopalakrishna A., Gummadi S.N. Over-expression of recombinant human phospholipid scramblase 1 in E. coli and its purification from inclusion bodies. Biotechnol. Lett. 2008, 30:2131-2137.
41. Huang K.T., Han T.H., Hyduke D.R., Vaughn M.W., Herle H.V., Hein T.W., Zhang C., Kuo L., Liao J.C. Modulation of nitric oxide bioavailability by erythrocytes. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:11771-11776.
42. Sen G., Mandal S., Roy S.S., Mukhopadhyay S., Biswas T. Therapeutic use of quercetin in the control of infection and anemia associated with visceral leishmaniasis. Free Radic. Biol. Med. 2005, 38:1257-1264.
43. Low F.M., Hampton M.B., Peskin A.V., Winterbourn C.C. Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood 2007, 109:2611-2617.
44. Choi B.M., Pae H.O., Jang S., Kim Y.M., Chung H.T. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J. Biochem. Mol. Biol. 2002, 35:116-126.
45. Evans T.G., Thai L., Granger D.L., Hibbs J.B. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J. Immunol. 1993, 151:907-915.
46. Melby P.C., Chandrasekar B., Zhao W., Coe J.E. The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response. J. Immunol. 2001, 166:1912-1920.
47. Murray H.W., Lu C.M., Mauze S., Freeman S., Moreira A.L., Kaplan G., Coffman R.L. Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect. Immun. 2002, 70:6284-6293.
48. Kleinbongard P., Schulz R., Rassaf T., Lauer T., Dejam A., Jax T., Kumara I., Gharini P., Kabanova S., Ozoyaman B., Schnorch H.G., Godecke A., Weber A., Robenek M., Robenek H., Bloch W., Rosen P., Kelm M. Red blood cells express a functional endothelial nitric oxide synthase. Blood 2006, 107:2943-2951.
49. Wanasen N., Soong L. l-Arginine metabolism and its impact on host immunity against Leishmania infection. Immunol. Res. 2008, 41:15-25.
50. Modolell M., Choi B.S., Ryan R.O., Hancock M., Titus R.G., Abebe T., Hailu A., Muller I., Rogers M.E., Bangham C.R.M., Munder M., Kropf P. Local suppression of T cell responses by arginase-induced l-arginine depletion in nonhealing leishmaniasis. PLoS Negl. Trop. Dis. 2009, 3:e480-e490.
51. Kropf P., Fuentes J.M., Fahnrich E., Arpa L., Herath S., Weber V., Soler G., Celada A., Modolell M., Muller I. Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo. Faseb J. 2005, 19:1000-1002.
52. Sen G., Mukhopadhyay R., Ghosal J., Biswas T. Oxidative damage of erythrocytes: a possible mechanism for premature hemolysis in experimental visceral leishmaniasis in hamsters. Ann. Hematol. 2001, 80:32-37.
53. Rossig L., Fichtlscherer B., Breitschopf K., Haendeler J., Zeiher A.M., Mulsch A., Dimmeler S. Nitric oxide inhibits caspase-3 by s-nitrosylation in vivo. J. Biol. Chem. 1999, 274:6823-6826.
54. Azad N., Vallyathan V., Wang L., Tantishaiyakul V., Stehlik C., Leonard S.S., Rojanasakul Y. S-nitrosylation of Bcl-2 inhibits its ubiquitin- proteasomal degradation a novel antiapoptotic mechanism that suppresses apoptosis. J. Biol. Chem. 2006, 281:34124-34134.
55. Mannick J.B. Regulation of apoptosis by protein s-nitrosylation. Amino Acids 2007, 32:523-526.
56. Fadok V.A., Bratton D.L., Rose D.M., Pearson A., Ezekewitz R.A.B., Henson P.M. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000, 405:85-90.
57. Balanco J.M.D.F., Moreira M.E.C., Bonomo A., Bozza P.T., Mendes G.A., Pirmez C., Barcinski M.A. Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbiocidal activity. Curr. Biol. 2001, 11:1870-1873.
58. Gomes F.L.R., Otero A.C., Gomes N.A., Moniz-de-Souza M.C.A., Finkelstein L.C., Arnholdt A.C., Calich V.L., Coutinho S.G., Lopes M.F., DosReis G.A. Macrophage interactions with neutrophils regulate Leishmania major infection. J. Immunol. 2004, 172:4454-4462.
59. Zwaal R.F.A., Schroit A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997, 89:1121-1132.
60. Lyu D., Atucha N.M., Martinez-prieto C., Ortiz M.C., Garcia-estan J. Altered calcium signaling in platelets from nitric oxide-deficient hypertensive rat. Cell Commun. Signal. 2004, 2:1-7.
61. Foller M., Feil S., Ghoreschi K., Koka S., Gerling A., Thunemann M., Hofmann F., Schuler B., Vogel J., Pichler B., Kasinathan R.S., Nicolay J.P., Huber S.M., Lang F., Feil R. Anemia and splenomegaly in cGKI-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:6771-6776.